Isu Abxis

Back in 2000, ISU ABXIS entered the therapeutic antibody market. Today, it is the nation's leading developer of therapeutic monoclonal antibodies. ISU ABXIS vows to become a competitive palyer worldwide through the steady expansion of research specialists and establishment of its consulting network of experts from top research institutions as well as by securing government grants for all its research projects, establishing highly efficient GMP manufactuirng facilities, and fostering a highly motivated marketing group with specialized expertise. In addition, it has increased the number of its professional research workers, networked with consultative bodies, implemented all projects under the sposorhip of the government, secured GMP based on a high-efficiency production system, and organize ...d its sales network. Such results will strengthen the international competitiveness of ISU ABXIS. Read more